Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven

Slides:



Advertisements
Similar presentations
Cervical Cancer.
Advertisements

Endometrial Cancer May 2007 Dr Anna Winship Guy’s & St. Thomas’ NHS Trust Click Here For First Question Oncology Registrars’ Forum “Best of Five”
Management of Endometrial Cancer dr Zohreh Yousefi / Fellowship of Gynecology Oncology Ghaem Hospital, Mashhad University of Medical Sciences.
Endometrial Cancer Surgical Staging (Role of Lymphadenectomy) Karl Podratz MD PhD FACS.
SURGICAL APPROACH TO GYNAECOLOGICAL CANCERS
Endometrial Cancer Tseng Jen-Yu 02/05/2007 Tseng Jen-Yu 02/05/2007.
 - an important step in surgical staging for uterine cancer (FIGO 1988)  Stated as 
SHELBY ADDISON NEAL, MD MENTORS: WILLIAM T. CREASMAN, MD WHITNEY S. GRAYBILL, MD, MS Lymph-Vascular Space Invasion (LVSI) in Uterine Corpus Cancer What.
A significant increase in the incidence of endometrial cancer. This increased incidence of endometrial cancer has been widely interpreted to be a result.
District 1 ACOG Medical Student Teaching Module 2009
Carcinoma of the Endometrium1 CARCINOMA OF THE ENDOMETRIUM Wen Di, M.D. , Ph.D.
Xi-Shi Liu Obstetrics and Gynecology Hospital Fudan university
Ji Young Lee, MD, PhD, David Marchetti, MD, M Steven Piver, MD Department of Obstetrics and Gynecology Sisters of Charity Hospital, Buffalo, NY The Clinical.
Endometrial Cancer ASSOCIATE PROFESSOR Iolanda Blidaru MD, PhD.
Gynaecologische Tumoren: Internationale richtlijnen en Nieuwe perspectieven in diagnostiek en behandeling SYMPOSIUM ONCOLOGIE – 7 JUNI 2008 Philippe Van.
Neoadjuvant Chemotherapy or Primary Debulking Surgery in Advanced Ovarian Cancer Ignace Vergote, MD PhD University Hospitals Leuven, Belgium IGCS Santa.
Endometrial Carcinoma Fuat Demirkıran, MD Istanbul University, Cerrahpaşa School Of Medicine, OB&GYN Department, Gyn Oncology.

Laparoscopic Surgical Management of Epithelial Ovarian Cancer Cagatay Taskiran, MD, Assoc. Prof. VKV American Hospital, Division of Gynecologic Oncology.
Fertility Sparing in Gynecological Cancers
Optimal Surgery for Ovarian and Endometrial Cancers Jason Dodge, MD, FRCSC, MEd May 11 th, 2012.
4% of all female cancers 25% of all gynecologic cancers life time risk: 1/70 ¾ advanced stage most lethal Epithelial Ovarian Cancer:
Pathologic Analysis of Tumour Destruction with Neutral Plasma in Epithelial Ovarian Carcinoma Madhuri TK 1, Butler-Manuel SA 1, Tailor A 1 & Haagsma B.
Dpt. Obstetrics & Gynecology Catholic University - Rome
Endometrial Carcinoma
Are there benefits from chemotherapy to early endometrial cancer
Lymphadenectomy in Epithelial Ovarian Cancer
ACRIN Abdominal Committee ACRIN Gynecologic Committee ACRIN 6671 GOG 0233 UPDATE ACRIN PI: M. ATRI GOG PI: M. GOLD.
Update on treatment modalities of uterine sarcomas Amant Frederic MD PhD Gynaecological Oncologist UZ Gasthuisberg Katholieke Universiteit Leuven Belgium.
Histopathological evaluation of lymphatic nodules in cancer of the uterine cervix Coordinators: First Author: Asist. Univ. Dr. Chira Liliana Stud. Bogdan.
Uterine Cancers A. Alobaid, MBBS, FRCS(C), FACOG Consultant, Gynecologic Oncology Assistant professor, KSU Medical Director, Women’s Specialized Hospital.
Oncology / Dysplasia Unit Royal Women’s Hospital, Carlton, Victoria Do all patients with invasive cervical carcinoma need a radical hysterectomy? Leuven.
Malignant & Pre-malignant Diseases of the Endometrium Jose B Moran MD Assistant Professor III Section of Gynecologic Oncology Department of Obstetrics.
Adjuvant treatment for endometrial cancer Ameri A Associate Professor of Radiation Oncology Shahid Beheshti University of Medical Sciences Dec Pars.
KARIMA SALAMA ENDOMETRIAL CANCER. Epidemiology Most common gynecological cancer in the developed countries, with an incidence of 12.9 per 100,000 women.
Metastatic Tumors of Ovary. METASTATIC TUMOR FROM BREAST CANCER both ovaries replaced by pale, rather nodular tumor, with breast cancer cells arranged.
Cancer of the Uterine Corpus and Cervix David Toub, M.D. Medical Director Newton Interactive.
David Cibula, VFN Innovation in surgical approach of ovarian cancer David Cibula Gynecologic Oncology Centre General Faculty Hospital in Prague.
Debulking in Ovarian Cancer Ashraf Fawzy Nabhan Assistant Prof. of Obstetrics & Gynecology Ain Shams University, Cairo, Egypt.
Department of Surgical, Oncological and Oral Sciences U.O.C Medical Oncology Director: Prof A. Russo Ovarian cancer Case Report 1 Dr. Lorena Incorvaia,
What’s New in Endometrial Cancer Henry Kitchener April 2009.
Management of Malignant Ovarian Germ Cell Tumors
Management of early stage cervical cancer
Shazia Bashir MD, MPH Gynecologic Oncologist
Primary Debulking vs NACT+IDS in EOC (PFS/OAS/Morbidity)
LION (Phase III Trial): Lymphadenectomy for LN-Negative Advanced Ovarian Cancer Following Complete Resection CCO Independent Conference Highlights* of.
FERTILITY SPARING IN OVARIAN CANCER
Over 1,000 robotic surgeries performed to date, and counting
Update of the management of
Dose dense chemotherapy in the adjuvant treatment of ovarian cancer
Uterine serous carcinoma is more aggressive than high-grade serous ovarian carcinoma: a retrospective study H. Nagano1, Y. Tachibana1, M. Kawakami1, M.
Zehra Nihal Dolgun, Ahmet Salih Altintas, Cihan Inan, Petek Balkanli
CARCINOMA OF THE ENDOMETRIUM
Laparoscopic Surgery in Gynaecologic Oncology An Added Value?
Overzicht activiteiten werkgroep medicamenteuze therapie
LaparoscopIc para-aortIc lymphadenectomy
Primaire behandeling van het endometrium carcinoma: Rol van lymfadenectomie, radiotherapie en chemotherapie Ignace Vergote PUS Gent 16/11/2006.
Surgery in Stage IIb-IV Ovarian Carcinoma
Dr.Amit Gupta Associate Professor Dept. of Surgery
Prof. Shaila Anwar Professor Obs & Gynae
Laparoscopic Surgery in Gynaecologic Oncology
Uterine cancer Uterine mesenchymal neoplasms
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer:
徐慧萍1 羅竹君1,2 郭耀隆1 李國鼎1 國立成功大學醫學院附設醫院外科部1 國立成功大學醫學院臨床醫學研究所2
Pericervical injection of 99mTc-Nanocolloid IS superior to peritumoral injection for sentinel lymph node detection in SPECT/CT Dr. Martin Weiss Department.
Management of endometrial cancer in Italy: A national survey endorsed by the Italian Society of Gynecologic Oncology  Stefano Greggi, Massimo Franchi,
Management of endometrial cancer found on routine hysterectomy for benign disease Prof Dr M Anıl Onan MAY ANTALYA.
ENDOMETRIAL CARCINOMA
Fallopian Tube Cancer Paweł Sadłecki
Presentation transcript:

Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven Indications and technique of pelvic and paraaortic lymphadenectomy Jaarcongres VVOG 8 en 9 okt 2010 Brussel Amant F – Gynecological Oncology - UZ Gasthuisberg, Leuven

Indications Pelvic lymphadenectomy Cervical cancer (Wertheim-Meigs) Endometrial cancer (+/- para aortic LA) Paraaortic lymphadenectomy Bulky or advanced stage cervical ca Endometrial cancer Ovarian cancer (+ pelvic LA)

Pathogenetic types of endometrial carcinoma Amant et al., Lancet 2005;366:591-605 Type 1 Type 2 Unopposed estrogen Present Absent Menopausal status Pre-and peri Post Precursor lesion Atypical hyperplasia Endometrial intraepithelial ca Tumour grade Low High Myometrial invasion Variable, often minimal Variable, often deep Histologic subtypes Endometrioid, gr 1-2 Serous, clear cell, endometrioid gr 3 Behavior Indolent Aggressive Genetic alterations PTEN mutation TP53 mutation Microsatellite instability K-ras mutation

Need for lymphadenectomy in endometrioid endometrial cancer Mariani et al., Am J Obstet Gynecol 2000;182:1506-19 N = 328 grade 1 or 2, myometrial invasion < 50%, no extrauterine disease Pelvic lymphadenectomy in 57%: 9/187 (5%) positive nodes No patient with tumour < 2cm: pos nodes or DOD Hysterectomy only if grade 1-2 < 2cm myometrial invasion < 50% no extra-uterine disease

Endometrial Carcinoma Clinical Stage I – FIGO 2009 Leuven Algorithm 2010 < 2cm, Stage Ia G1-G2 or > 2cm, G1 < 1/3 infiltr AHT/LAVH + BSO Peritoneal Cytology No Adjuvant Therapy Endometrioid Stage Ib, or G3, or > 2cm, G1 > 1/3 or Serous/Clear cell Pelvic Lymphadenectomy Neg Pelvic Ln No Adjuvant Therapy, unles Endometrioid G3: Paclitaxel Carbo x 6 Pos Pelvic Ln Paclitaxel/Carbo 6x+ Macro/frozen section Pelv Ln + Macro Pos Adnex Growth through serosa Paraaortic Lymphadenectomy to renal vessels Neg PAO/Pos Pelvic: Paclitaxel/Carbo Pelvic RT Pos PAO and Pelvic: Paclitaxel/Carbo x 6 Pelvic + PAO RT

Video pelviC LYMPHADENECTOMY

indications Pelvic lymphadenectomy Cervical cancer (Wertheim-Meigs) Endometrial cancer (+/- para aortic LA) Paraaortic lymphadenectomy Bulky or advanced stage cervical ca Endometrial cancer Ovarian cancer (+ pelvic LA)

Incisions for retroperitoneal laparoscopic lymphadenectomy

laparoscopic PARA AORTIC NODE RESECTION

Metastasis above IMA in 77% But: based on 26 patients only paraaortic node metastases in endometrial cancer Mariani et al., Gynecol Oncol 2008 IMA Metastasis above IMA in 77% But: based on 26 patients only

Survival effect of para-aortic lymphadenectomy in endometrial cancer (sepal study): a retrospective cohort analysis Todo et al., Lancet 2010;375:1165-72 N = 671 But: retrospective important differences in adjuvant treatment Overall Survival Disease specific survival

Prognostic importance of degree of differentiation in stage I invasive epithelial ovarian cancer (n=1545) Vergote et al., Lancet 2001 – Zanetta et al., Ann Oncol 1998 – Trimbos et al., JNCI 2003

Impact of surgical staging in early-stage ovarian cancer Trimbos, J.B. et al., J. Natl. Cancer Inst. 2003 95:113-125 – Zanetta G., Ann Oncol 1998 Copyright restrictions may apply.

Pelvic and paraaortic ln in oc (all stages) Burghardt et al., Gynecol Oncol 1991;40:103-6 Stage N P+ Ao+ P+ Ao- P- Ao+ P- Ao- I 20 1(5%) 2(10%) 17(85%) II 7 3(43%) 1(14%) 2(29%) III 67 34(51%) 9(13%) 15(22%) IV 11 8(73%) 1(9%) 2(18%) Total 105 46(44%) 13(12%) 10(9%) 36(35%)

Du Bois, A. et al., J Clin Oncol; 28:1733-1739 2010 Overall survival (OS) in advanced stage ovarian cancer patients with or without lymphadenectomy (LNE) Du Bois, A. et al., J Clin Oncol; 28:1733-1739 2010 Lymphadenectomy should be restricted to patients in whom the removal of clinically suspect lymph node metastases improves The residual disease status

Indications for lymphadenectomy in gynaecological oncology Pelvic lymphadenectomy Cervical cancer (Wertheim-Meigs) Endometrial cancer (high grade, tumor diameter, myometrial invasion) Paraaortic lymphadenectomy Bulky or advanced stage cervical ca Endometrial cancer Ovarian M+ Positive pelvic nodes Serosal involvement Ovarian cancer ( always + pelvic LA) High grade early stage Part of a debulking procedure to R0